Source:http://linkedlifedata.com/resource/pubmed/id/18974155
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
21
|
pubmed:dateCreated |
2008-10-31
|
pubmed:abstractText |
Common sites of breast cancer metastasis include the lung, liver, and bone, and of these secondary metastatic sites, estrogen receptor alpha (ERalpha)-positive breast cancer often favors bone. Within secondary organs, cancer cells would predictably encounter tissue-specific fibroblasts or their soluble factors, yet our understanding of how tissue-specific fibroblasts directly affect cancer cell growth rates and survival remains largely unknown. Therefore, we tested the hypothesis that mesenchymal fibroblasts isolated from common sites of breast cancer metastasis provide a more favorable microenvironment with respect to tumor growth rates. We found a direct correlation between the ability of breast, lung, and bone fibroblasts to enhance ERalpha-positive breast cancer cell growth and the level of soluble interleukin-6 (IL-6) produced by each organ-specific fibroblast, and fibroblast-mediated growth enhancement was inhibited by the removal or inhibition of IL-6. Interestingly, mice coinjected with MCF-7 breast tumor cells and senescent skin fibroblasts, which secrete IL-6, developed tumors, whereas mice coinjected with presenescent skin fibroblasts that produce little to no IL-6 failed to form xenograft tumors. We subsequently determined that IL-6 promoted growth and invasion of breast cancer cells through signal transducer and activator of transcription 3-dependent up-regulation of Notch-3, Jagged-1, and carbonic anhydrase IX. These data suggest that tissue-specific fibroblasts and the factors they produce can promote breast cancer disease progression and may represent attractive targets for development of new therapeutics.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1538-7445
|
pubmed:author |
pubmed-author:BonaféMassimilianoM,
pubmed-author:ChanMichael W YMW,
pubmed-author:HallBrett MBM,
pubmed-author:HuangTimT,
pubmed-author:MariniFrank CFC,
pubmed-author:RosolThomas JTJ,
pubmed-author:SansonePasqualeP,
pubmed-author:SasserA KateAK,
pubmed-author:StorciGianlucaG,
pubmed-author:StudebakerAdam WAW,
pubmed-author:TavolariSimonaS,
pubmed-author:WerbeckJillian LJL
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9087-95
|
pubmed:meshHeading |
pubmed-meshheading:18974155-Breast Neoplasms,
pubmed-meshheading:18974155-Cell Division,
pubmed-meshheading:18974155-Cell Line, Tumor,
pubmed-meshheading:18974155-Culture Media, Conditioned,
pubmed-meshheading:18974155-Fibroblasts,
pubmed-meshheading:18974155-Humans,
pubmed-meshheading:18974155-Immunoprecipitation,
pubmed-meshheading:18974155-Interleukin-6,
pubmed-meshheading:18974155-Neoplasm Invasiveness,
pubmed-meshheading:18974155-Neoplasm Metastasis,
pubmed-meshheading:18974155-Phosphorylation,
pubmed-meshheading:18974155-RNA Interference,
pubmed-meshheading:18974155-STAT3 Transcription Factor
|
pubmed:year |
2008
|
pubmed:articleTitle |
Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.
|
pubmed:affiliation |
Center for Childhood Cancer, Children's Research Institute, WA 5015, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|